Astellas Adds 2nd Patent To Urinary Drug IP Fight With Teva
Japanese pharmaceutical giant Astellas has filed a new lawsuit in its ongoing fight with Teva over a incontinence drug, telling a court that if the generic drugmaker is allowed to enter...To view the full article, register now.
Already a subscriber? Click here to view full article